|
市場調査レポート
商品コード
1226779
北米の左心室補助装置市場の2028年までの予測- 地域別分析- フローの種類別、デザイン別、用途別North America Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Type of Flow, Design, and Application |
||||||
|
|
|||||||
| 北米の左心室補助装置市場の2028年までの予測- 地域別分析- フローの種類別、デザイン別、用途別 |
|
出版日: 2023年01月24日
発行: The Insight Partners
ページ情報: 英文 104 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
北米の左心室補助装置市場は、2022年の5億4,059万米ドルから2028年には7億3,928万米ドルに成長すると予測されています。2022年から2028年までのCAGRは5.4%で成長すると推定されています。
老年人口の増加が北米の左心室補助装置市場の成長に貢献
老年人口は、CVD、整形外科疾患、代謝疾患、神経疾患などの疾患に罹患しやすいです。米国国勢調査局によると、2009年には米国の人口の約13％が65歳以上であり、2030年末には20％増加すると推定されています。エモリーヘルスケアの調査によると、米国では65歳以上の約140万人がうっ血性心不全を患っており、60～69歳の5％以上がうっ血性心不全を患っています。また、うっ血性心不全の年間発症率は、65歳以上で1,000人あたり10人となっています。うっ血性心不全は、65歳以上の年齢の患者さんに最も多い診断の一つであり、この疾患により2021年には米国で875,000件の入院が発生しています。左心室補助装置は、老年人口における末期心不全の管理に広く使用されています。したがって、高齢化人口の増加と心不全の有病率の増加は、北米の左心室補助装置市場に燃料を供給します。
北米の左心室補助装置市場の概要
北米の左心室補助装置市場は、米国、カナダ、メキシコに区分されます。同地域は、特に高齢者層における心血管疾患の蔓延により、2021年の左心室補助装置世界市場で最大のシェアを占めています。また、心不全患者の増加やLVAD関連費用の保険適用も、北米の左心室補助装置市場の成長に寄与しています。
北米の左心室補助装置市場の収益と2028年までの予測
北米の左心室補助装置市場のセグメンテーション
北米の左心室補助装置市場は、流れの種類、デザイン、用途、国別にセグメント化されています。
北米の左心室補助装置市場は、流れの種類によって非脈動性と脈動性に分けられます。2022年には、非脈動性セグメントがより大きな市場シェアを記録しました。
北米の左心室補助装置市場は、デザイン別に、植込み型心室補助装置と経皮的心室補助装置に二分されます。2022年はマネージドサービス分野がより大きな市場シェアを占めています。
用途別では、北米の左心室補助装置市場は、目的地治療、移植への橋渡し、候補地への橋渡し、回復への橋渡しに区分されます。2022年には、目的地治療分野が最大の市場シェアを占めています。
北米の左心室補助装置市場は、国別に、米国、カナダ、メキシコに区分されます。2022年は米国が市場を独占しました。
AO Kaspersky Lab;Avast Software s.r.o.;Cisco Systems, Inc.;ESET, spol. s r.o.;Fortinet, Inc.;McAfee, LLC;Microsoft Corporation;and Palo Alto Networks, Inc.が北米の左心室補助装置市場で事業を展開している主要企業です。
目次
第1章 イントロダクション
第2章 重要なポイント
第3章 調査手法
- カバレッジ
- 2次調査
- 1次調査
第4章 北米における左心室補助装置市場- 市場展望
- PEST分析
- 専門家の見解
第5章 北米の左心室補助装置市場- 主要な市場力学
- 市場促進要因
- 対象疾患と手術の発生率の上昇
- 老年人口の増加
- 市場抑制要因
- 左心室補助装置に関連する製品回収と合併症の増加
- 今後の動向
- LVADにおける人工知能と機械学習の使用の増加
- 影響分析
第6章 北米の左心室補助装置市場分析
- 北米の左心室補助装置の市場収益と予測・分析
第7章 北米の左心室補助装置市場の分析- フローの種類別
- 北米の左心室補助装置市場、フローの種類別、2021年・2028年（%）
- 拍動性フロー
- 非脈動性フロー
第8章 北米の左心室補助装置市場の分析- デザイン別
- 北米の左心室補助装置市場：デザイン別、2021 &2028（%）
- 植込み型心室補助装置
- 経皮的心室補助装置
第9章 北米の左心室補助装置市場分析- 用途別
- 北米の左心室補助装置市場：用途別2021年・2028年（%）
- 移植への橋渡し
- デスティネーションセラピー
- 回復への橋渡し
- 候補への橋渡し
第10章 北米の左心室補助装置市場- 国別分析
- 北米
- 米国
- カナダ
- メキシコ
第11章 企業プロファイル
- ABIOMED Inc
- Abbott Laboratories
- Medtronic Plc
- LivaNova Plc
- Terumo Corp
- Berlin Heart GmbH
- BiVACOR Inc
- Evaheart Inc
- BioVentrix Inc
第12章 付録
List Of Tables
- Table 1. US: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
- Table 2. US: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
- Table 3. US: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 4. Canada: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Canada: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
- Table 6. Canada: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Mexico: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Mexico: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Mexico: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Glossary of Terms
List Of Figures
- Figure 1. North America Left Ventricular Assist Device Market Segmentation
- Figure 2. North America Left Ventricular Assist Device Market, By Country
- Figure 3. North America Left Ventricular Assist Device Market Overview
- Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in North America Left Ventricular Assist Device Market
- Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
- Figure 6. North America: PEST Analysis
- Figure 7. Experts Opinion
- Figure 8. Impact Analysis
- Figure 9. North America Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
- Figure 10. North America Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
- Figure 11. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 12. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 13. North America Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
- Figure 14. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 15. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 16. North America Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
- Figure 17. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 18. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 19. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 20. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 21. North America: Left Ventricular Assist Device Market Revenue Overview, By Key Country - Revenue (2021) (US$ Million)
- Figure 22. North America: Left Ventricular Assist Device Market, By Country, 2021 & 2028 (%)
- Figure 23. US: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Canada: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Mexico: Left Ventricular Assist Device Market Revenue and Forecast To 2028 (US$ Million)
The North America left ventricular assist device market is expected to grow from US$ 540.59 million in 2022 to US$ 739.28 million by 2028. It is estimated to record a CAGR of 5.4% from 2022 to 2028.
Increasing Geriatric Population Contributes to Market Growth of North America Left Ventricular Assist Device Market
The geriatric population is prone to conditions such as CVDs, orthopedic disorders, metabolic disorders, and neurological disorders. According to the US Census Bureau, ~13% of the population in the US was aged 65 and above in 2009, which is estimated to increase by 20% by the end of 2030. Per a study by Emory Healthcare, in the US, ~1.4 million people of age more than 65 have congestive heart failure, and more than 5% of people aged 60-69 have congestive heart failure. Additionally, the annual incidence of congestive heart failure is 10 per 1,000 among people aged 65 and above. Congestive heart failure is one of the most common diagnoses in patients of age 65 and above age, and the condition led to 875,000 hospitalizations in the US in 2021. Left ventricular assist devices are widely used in managing end-stage heart failure in the geriatric population. Hence, the elevating aging population base and the increasing prevalence of heart failure in this population fuel the North America left ventricular assist device market .
North America Left Ventricular Assist Device Market Overview
The North America left ventricular assist device market is segmented into the US, Canada, and Mexico. The region accounted for the largest share of the global left ventricular assist device market in 2021 owing to the prevalence of cardiovascular diseases, especially in the geriatric population. A rise in the cases of heart failure and the inclusion of LVAD-associated costs under insurance are also contributing to the growth of the North America left ventricular assist devices market.
North America Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
North America Left Ventricular Assist Device Market Segmentation
The North America left ventricular assist device market has been segmented on the basis of type of flow, design, and application, and country.
Based on the type of flow, the North America left ventricular assist device market is segmented into non-pulsatile and pulsatile flow . The non-pulsatile segment registered a larger market share in 2022.
The North America left ventricular assist device market, by design, is bifurcated into implantable ventricular assist devices and transcutaneous ventricular assist devices . The managed services segment accounted for a larger market share in 2022.
In terms of application, the North America left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery . The destination therapy segment held the largest market share in 2022.
The North America left ventricular assist device market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
AO Kaspersky Lab; Avast Software s.r.o.; Cisco Systems, Inc.; ESET, spol. s r.o.; Fortinet, Inc.; McAfee, LLC; Microsoft Corporation; and Palo Alto Networks, Inc. are the leading companies operating in the North America left ventricular assist device market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America left ventricular assist device market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America left ventricular assist device market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the left ventricular assist device market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 North America Left Ventricular Assist Device Market - By Type of Flow
- 1.3.2 North America Left Ventricular Assist Device Market - By Design
- 1.3.3 North America Left Ventricular Assist Device Market - By Application
- 1.3.4 North America Left Ventricular Assist Device Market - By Country
2. Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Left Ventricular Assist Device Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Experts Opinion
5. North America Left Ventricular Assist Device Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Incidence of Target Diseases and Procedures
- 5.1.2 Uplifting Geriatric Population
- 5.2 Market Restraints
- 5.2.1 Rise in Product Recalls and Complications Associated with Left Ventricular Assist Devices
- 5.3 Future Trends
- 5.3.1 Increased Use of Artificial Intelligence and Machine Learning in LVAD
- 5.4 Impact Analysis
6. North America Left Ventricular Assist Device Market Analysis
- 6.1 North America Left Ventricular Assist Device Market Revenue Forecast & Analysis
7. North America Left Ventricular Assist Device Market Analysis - By Type of Flow
- 7.1 Overview
- 7.2 North America Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
- 7.3 Pulsatile Flow
- 7.3.1 Overview
- 7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
- 7.4 Non-Pulsatile
- 7.4.1 Overview
- 7.4.2 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
8. North America Left Ventricular Assist Device Market Analysis - by Design
- 8.1 Overview
- 8.2 North America Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
- 8.3 Implantable Ventricular Assist Devices
- 8.3.1 Overview
- 8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
- 8.4 Transcutaneous Ventricular Assist Devices
- 8.4.1 Overview
- 8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
9. North America Left Ventricular Assist Device Market - By Application
- 9.1 Overview
- 9.2 North America Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
- 9.3 Bridge to Transplantation
- 9.3.1 Overview
- 9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
- 9.4 Destination Therapy
- 9.4.1 Overview
- 9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
- 9.5 Bridge to Recovery
- 9.5.1 Overview
- 9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
- 9.6 Bridge to Candidacy
- 9.6.1 Overview
- 9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)
10. North America Left Ventricular Assist Device Market - Country Analysis
- 10.1 Overview
- 10.1.2 North America: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
- 10.1.2.1 US: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.1 Overview
- 10.1.2.1.2 US: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.3 US: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
- 10.1.2.1.4 US: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
- 10.1.2.1.5 US: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
- 10.1.2.2 Canada: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.1 Overview
- 10.1.2.2.2 Canada: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.3 Canada: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
- 10.1.2.2.4 Canada: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
- 10.1.2.2.5 Canada: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
- 10.1.2.3 Mexico: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.1 Overview
- 10.1.2.3.2 Mexico: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.3 Mexico: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
- 10.1.2.3.4 Mexico: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
- 10.1.2.3.5 Mexico: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
- 10.1.2.1 US: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2 North America: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
11. Company Profiles
- 11.1 ABIOMED Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Abbott Laboratories
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Medtronic Plc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 LivaNova Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Terumo Corp
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Berlin Heart GmbH
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 BiVACOR Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Evaheart Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 BioVentrix Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
